NovaBridge Biosciences Impairment of Intangible Assets, Finite-lived
NovaBridge Biosciences (NBP) reported Impairment of Intangible Assets, Finite-lived of CNY 0 for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2024-04-30
- NovaBridge Biosciences impairment of intangible assets, finite-lived for the quarter ending 2020-12-31 was 0.00 CNY.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|---|---|---|
| 2023-12-31 | 0.00 CNY 20-F · filed 2024-04-30 | |||
| 2022-12-31 | 0.00 CNY 20-F · filed 2024-04-30 | |||
| 2022-06-30 | 0.00 CNY 6-K · filed 2022-11-10 | |||
| 2021-12-31 | 0.00 CNY 20-F · filed 2023-05-01 | |||
| 2020-12-31 | 0.00 CNY derived: 20-F 12 month − 6-K 9 month · filed 2022-04-29 | 0.00 CNY 20-F · filed 2022-04-29 | ||
| 2020-09-30 | 0.00 CNY 6-K · filed 2021-02-05 | |||
| 2019-12-31 | 0.00 CNY 20-F · filed 2021-04-28 | |||
| 2018-12-31 | 0.00 CNY 20-F · filed 2020-04-29 |